BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7538361)

  • 1. [Contribution of chemotherapy in the treatment of cancer of the cavum (UCNT): apropos of 47 cases].
    Poupart M; Damiano J; Bolot G; Biron P; Caldentey L; Ardiet JM; Pignat JC
    Bull Cancer; 1994 May; 81(5):366-70. PubMed ID: 7538361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
    Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Induction polychemotherapy before radiotherapy in carcinoma of the cavum. The experience of the Ibn Rochd-Casablanca Oncology Centre].
    Samlali R; Acharki A; Sahraoui S; Benider A; Kahlain A
    Bull Cancer Radiother; 1996; 83(2):111-4. PubMed ID: 8688217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcomes of patients with AJCC stage IVC nasopharyngeal carcinoma: benefits of primary radiotherapy.
    Yeh SA; Tang Y; Lui CC; Huang EY
    Jpn J Clin Oncol; 2006 Mar; 36(3):132-6. PubMed ID: 16520357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
    Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ
    J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multimodality treatment of nasopharyngeal carcinoma].
    Tanaka J; Inuyama Y; Fujii M; Takaoka T; Hosoda H; Kohno N
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1789-96. PubMed ID: 2439016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma.
    Hareyama M; Sakata K; Shirato H; Nishioka T; Nishio M; Suzuki K; Saitoh A; Oouchi A; Fukuda S; Himi T
    Cancer; 2002 Apr; 94(8):2217-23. PubMed ID: 12001120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
    Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
    Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy with continuous infusion of cisplatin and 5-fluorouracil, with or without leucovorin, for locally advanced nasopharyngeal carcinoma.
    Fonseca E; Cruz JJ; Rodríguez CA; Gómez-Bernal A; Martín G; Sánchez P; Nieto A; Soria P; Vega MJ; Muñoz A; Pardal JL
    J Infus Chemother; 1996; 6(4):217-20. PubMed ID: 9229319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma.
    Fuchs S; Rödel C; Brunner T; Iro H; Niedobitek G; Sauer R; Grabenbauer GG
    Onkologie; 2003 Feb; 26(1):12-8. PubMed ID: 12624512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.
    Lee CC; Chu ST; Chou P
    Auris Nasus Larynx; 2009 Dec; 36(6):688-94. PubMed ID: 19410399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metastatic nasopharyngeal carcinoma: clinical study and therapeutic results of 95 cases].
    Khanfir A; Frikha M; Ghorbel A; Karray H; Drira MM; Daoud J
    Cancer Radiother; 2006 Dec; 10(8):545-9. PubMed ID: 16807035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials.
    Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Au GK; Min HQ
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1300-6. PubMed ID: 16750333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
    Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant chemotherapy and radiotherapy for locally advanced nasopharyngeal carcinoma.
    Cheng SH; Liu TW; Jian JJ; Tsai SY; Hao SP; Huang CH; Liu MC; Yu B; Huang AT
    Cancer J Sci Am; 1997; 3(2):100-6. PubMed ID: 9099460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
    Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasopharyngeal carcinoma in childhood and adolescence: a single-institution experience with combined therapy.
    Zubizarreta PA; D'Antonio G; Raslawski E; Gallo G; Preciado MV; Casak SJ; Scopinaro M; Morales G; Sackmann-Muriel F
    Cancer; 2000 Aug; 89(3):690-5. PubMed ID: 10931470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
    Chua DT; Nicholls JM; Sham JS; Au GK
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):11-20. PubMed ID: 15093894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.